A dose-ranging trial of a matrix transdermal 17β-estradiol for the prevention of bone loss in early postmenopausal women

Bone

Volumn 24, Issue 5, 1999, Pages 517-523

  Delmas, P D ^a   Pornel, B ^b   Felsenberg, D ^c   Garnero, P ^a   Hardy, P ^d   Pilate, C ^d   Dain, M P ^d  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b Brussels Menopause Center   (Belgium)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d SANOFI   (France)

Author keywords

Bone loss; Bone mineral density; Bone resorption markers; Dual energy X ray absorptiometry; Estradiol; Menopause

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; COLLAGEN TYPE 1; DYDROGESTERONE; ESTRADIOL; OSTEOCALCIN; PLACEBO;

ADULT; ARTICLE; BONE ATROPHY; BONE MINERAL; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FEMUR; HUMAN; HUMAN TISSUE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MASTALGIA; MULTICENTER STUDY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SKIN DISEASE; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; BONE DENSITY; DENSITOMETRY, X-RAY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; TREATMENT OUTCOME;

EID: 0032903034     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(99)00076-9     Document Type: Article

References (26)

1. Arlot M.E., Sornay-Rendu E., Garnero P., Vey-Marty B., Delmas P.D. Apparent pre- and postmenopausal bone loss evaluated by DXA at different skeletal sites in women The OFELY cohort . J Bone Miner Res. 12:1997;683-690.
2. Balfour J.A., Heel R.C. Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints. Drugs. 40:1990;561-582.
3. Delmas P.D. Hormone replacement therapy in the prevention and treatment of osteoporosis. Osteopor Int. 7:(Suppl. 1):1997;S3-S7.
4. Delmas P.D., Garnero P. Biological markers of bone turnover in osteoporosis. Stevenson J.C., Lindsay R. Osteoporosis. 1998;117-136 Chapman & Hall, London.
5. Ettinger B., Genant H.K., Cann C.E. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med. 102:1985;319-324.
6. Evans S.F., Davie M.W. Low and conventional dose transdermal estradiol are equally effective at preventing bone loss in spine and femur at all post-menopausal ages. Clin Endocrinol. 44:1996;79-84.
7. Field C.S., Ory S.J., Wahner H.W., Herrmann R.R., Judd H.L., Riggs B.L. Preventive effects of transdermal 17 beta-estradiol on osteoporotic changes after surgical menopause A two-year placebo-controlled trial . Am J Obstet Gynecol. 168:1993;114-121.
8. Garnero P., Hausherr E., Chapuy M.C., Marcelli C., Grandjean H., Muller C., Cormier C., Breart G., Meunier P.J., Delmas P.D. Markers of bone resorption predict hip fracture in elderly women The EPIDOS prospective study . J Bone Miner Res. 11:1996;1531-1538.
9. Garnero P., Sornay-Rendu E., Chapuy M.C., Delmas P.D. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res. 11:1996;337-349.
10. Grodstein F., Stampfer M.J., Colditz G.A., Willet W.C., Manson J.E., Joffe M., Rosner B., Fuchs C., Hankinson S.E., Hunter D.J., Hennekens C.H., Speizer F.E. Postmenopausal hormone therapy and mortality. N Engl J Med. 336:1997;1769-1775.
11. Hillard T.C., Witcroft S.J., Marsh M.S., Ellerington M.C., Lees B., Whitehead M.I., Stevenson J.C. Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss. Osteopor Int. 4:1994;341-348.
12. Lievertz R.W. Pharmacology and pharmacokinetics of estrogens. Am J Obstet Gynecol. 156:1987;1289-1293.
13. Lindsay R., Hart D.M., Aitken J.M., MacDonald E.B., Anderson J.B., Clarke A.C. Long-term prevention of postmenopausal osteoporosis by estrogen Evidence for an increased bone mass after delayed onset of estrogen treatment . Lancet. i:1976;1038-1041.
14. Lufkin E.G., Wahner H.W., O'Fallon W.M., Hodgson S.F., Kotowicz M.A., Lane A.W., Judd H.L., Caplan R.H., Riggs B.L. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med. 117:1992;1-9.
15. Marty J.P. Menorest Technical development and pharmacokinetic profile . Eur J Obstet Gynecol Reprod Biol. 64:(Suppl.):1996;S29-S33.
16. Naessen T., Persson I., Adami H.O., Bergstrom R., Bergkvist L. Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study. Ann Intern Med. 113:1990;95-103.
17. O'Connell M.B. Pharmacokinetic and pharmacologic variation between different estrogen products. J Clin Pharmacol. 35:(Suppl.):1995;18S-24S.
18. Pornel B. Efficacy and safety of Menorest in two positive-controlled studies. Eur J Obstet Gynecol Reprod Biol. 64:(Suppl.):1996;S35-S37.
19. Ribot C., Tremollieres F., Pouilles J.M., Louvet J.P., Peyron R. Preventive effects of transdermal administration of 17 beta-estradiol on postmenopausal bone loss A 2-year prospective study . Gynecol Endocrinol. 3:1989;259-267.
20. Riggs B.L., Melton L.J. The worldwide problem of osteoporosis Insights afforded by epidemiology . Bone. 17:(Suppl.):1995;505S-511S.
21. Riggs B.L., Melton L.J., O'Fallon W.M. Drug therapy for vertebral fractures in osteoporosis Evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy . Bone. 18:(Suppl.):1996;197S-201S.
22. Rowe R. Osteoporosis care - the need for a district-wide approach. Br J Clin Pract. 50:1996;342-343.
23. Rozenbaum H., Birkhäuser M., De Nooyer C., Lambotte R., Pornel B., Schneider H., Studd J., Thebault J. Comparison of two estradiol transdermal systems (Oesclim 50 and Estraderm TTS 50) II. Local skin tolerability . Maturitas. 25:1996;175-185.
24. Rozenbaum H., Birkhäuser M., De Nooyer C., Lambotte R., Pornel B., Schneider H., Studd J. Comparison of two estradiol transdermal systems (Oesclim 50 and Estraderm TTS 50) I. Tolerability, adhesion and efficacy . Maturitas. 25:1996;161-173.
25. Studd J.W., McCarthy K., Zamblera D., Burger H.G., Silberberg S., Wren B., Dain M.P., Le Lann L., Vandepol C. Efficacy and tolerance of Menorest compared to Premarin in the treatment of postmenopausal women A randomised, multicentre, double-blind, double-dummy study . Maturitas. 22:1995;105-114.
26. Tamhane A.C., Hochberg Y., Dunnett C.W. Multiple test procedures for dose finding. Biometrics. 52:1996;21-37.